Takeda Pharmaceutical Company Limited
武田薬品工業株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4502
FY2025 · 2026-03-31
| Gross margin | 65.1% |
| Operating margin | 0.1% |
| Net margin | -3.4% |
| Return on equity | -2.1% |
| Return on assets | -1.0% |
| Revenue growth (YoY) | -1.7% |
| EPS (basic) | ¥-96.75 |
| EPS growth (YoY) | -241.5% |
| Current ratio | — |
| Equity ratio | 47.9% |
| Book value / share | ¥2,378.68 |
| Free cash flow | 865,428 M |